No effect of risedronate on femoral periprosthetic bone loss following total hip arthroplasty. A 4-year follow-up of 61 patients in a double-blind, randomized placebo-controlled trial (Q36044250)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No effect of risedronate on femoral periprosthetic bone loss following total hip arthroplasty. A 4-year follow-up of 61 patients in a double-blind, randomized placebo-controlled trial |
scientific article |
Statements
1 reference
No effect of risedronate on femoral periprosthetic bone loss following total hip arthroplasty. A 4-year follow-up of 61 patients in a double-blind, randomized placebo-controlled trial (English)
1 reference
André Stark
1 reference
Olof Sköldenberg
1 reference
Olle Muren
1 reference
Ehsan Akbarian
1 reference
Mats Salemyr
1 reference
Henrik Bodén
1 reference
Thomas Eisler
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference